Our data showed for the first time that Wnt5A–ROR2 is modulated by inflammatory mediators and inflammatory pathways, and this prompted us to assess the role of Wnt5A–ROR2 in ovarian cancer migration. This evidence concerns the gene ROR2 and ovarian cancer.